Montefiore Opioid and Pain Study (MOPS)

February 16, 2022 updated by: Montefiore Medical Center
This study will determine pain and opioid outcomes 3 & 6 months after an emergency department visit for acute pain. This is an observational study. Patients are enrolled during an ED visit and followed by telephone 3 & 6 months later. Opioid databases will also be reviewed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

462

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Bronx, New York, United States, 10467
        • Montefiore Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Emergency department patients who are evaluated for acute pain and are prescribed an oral opioid

Description

Inclusion Criteria:

  • Adults seen in the emergency department for acute, new-onset pain, defined as: 1)localized pain duration < 10 days and 2) prior to the acute episode, the patient has not had this type of pain in the preceding six months
  • Upon emergency department discharge, the patients is prescribed an opioid for pain

Exclusion Criteria:

  • Any prescribed opioid use within the previous six months including methadone and buprenorphine

    • Frequent use of any analgesic medication (Use of any analgesic >10 days per month prior to the onset of acute pain)
    • Not available for follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subsequent opioid prescription
Time Frame: 6 months
All participants in this study received an opioid prescription at the time of discharge from the emergency department. Using a review of a prescription monitoring database, this study will determine whether participants received a subsequent prescription for an opioid medication.
6 months
Chronic pain in the affected body part
Time Frame: 6 months
An affirmative response to the following question: its been about 180 days since you left the ER. Have you had pain on more than 50% of these days?
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3 item PEG score
Time Frame: 3 months and 6 months after ED discharge
This is a validated pain questionnaire with 3 questions
3 months and 6 months after ED discharge
Pain description
Time Frame: 3 months and 6 months after ED discharge
Severe, moderate, mild or no pain
3 months and 6 months after ED discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 8, 2017

Primary Completion (ACTUAL)

February 15, 2022

Study Completion (ACTUAL)

February 15, 2022

Study Registration Dates

First Submitted

December 12, 2017

First Submitted That Met QC Criteria

December 14, 2017

First Posted (ACTUAL)

December 18, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 17, 2022

Last Update Submitted That Met QC Criteria

February 16, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pain

Clinical Trials on Any oral opioid

3
Subscribe